Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients

Le Page, Emmanuelle; Leray, Emmanuelle; Taurin, Grégory; Coustans, Marc; Chaperon, J; P Morrissey, S.; Edan, Gilles

doi:10.1136/jnnp.2007.124958

Public

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients

Published in Journal of Neurology Neurosurgery & Psychiatry • Sep 11, 2007

Authors:

Emmanuelle Le Page

Emmanuelle Leray

Grégory Taurin

Abstract

BACKGROUND: Mitoxantrone was approved by the French health authority (AFSAPPS) in October 2003 to treat patients with aggressive multiple sclerosis (MS). OBJECTIVE: To report the long term effectiveness and safety of mitoxantrone as induction therapy in patients with aggressive relapsing-remitting M...

Subject

Mitoxantrone

Medicine

Multiple sclerosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!